// App-Quantinova.ai

3198 : HDAC inhibitor panobinostat as a selective agent, synergizes with chemotherapeutics in medulloblastoma and neuroblastoma

Researchers

Presenter

  • Amanda B. Witte

Principal Investigators

  • Mary Durston

  • Ping Zhao

  • Abhinav B. Nagulapally

  • Jeffrey Bond

  • Giselle L. Saulnier Sholler

Medical Centers

  • Michigan State University College of Human Medicine and Helen DeVos Children's Hospital, Grand Rapids, MI

  • Helen DeVos Children's Hospital, Grand Rapids, MI.

  • University of Vermont, Burlington, VT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Medulloblastoma

  • Neuroblastoma

  • Brain cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Panobinostat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved